4.7 Article

Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Geriatrics & Gerontology

Evaluation of Error Production in Animal Fluency and Its Relationship to Frontal Tracts in Normal Aging and Mild Alzheimer's Disease: A Combined LDA and Time-Course Analysis Investigation

Yoshihiro Itaguchi et al.

Summary: The occurrence of intrusions and left hemisphere degeneration of frontal tracts is a pathognomonic trait of mild Alzheimer's disease. This suggests that the error commission in patients with AD is associated with executive and working memory impairments related to deteriorated left frontal tracts.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Article Clinical Neurology

Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers

Shorena Janelidze et al.

Summary: This study aimed to determine which plasma biomarker combinations can accurately detect tau pathological brain changes in Down syndrome (DS). The results showed that plasma p-tau217 and GFAP were closely associated with abnormal tau-PET and A beta-PET status, and p-tau217 was associated with cognitive impairment in DS.

JAMA NEUROLOGY (2022)

Article Psychiatry

Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease

Pratishtha Chatterjee et al.

Summary: The study found that plasma GFAP levels are elevated in cognitively normal older adults at risk of AD, indicating that astrocytic damage or activation may start from the pre-symptomatic stage of the disease and is associated with brain Aβ load. The potential of plasma GFAP to contribute to a diagnostic blood biomarker panel, along with plasma Aβ 1-42/Aβ 1-40 ratios, for cognitively normal older adults at risk of AD was highlighted by the observations from the present study.

TRANSLATIONAL PSYCHIATRY (2021)

Article Medicine, General & Internal

Cross-Sectional Exploration of Plasma Biomarkers of Alzheimer's Disease in Down Syndrome: Early Data from the Longitudinal Investigation for Enhancing Down Syndrome Research (LIFE-DSR) Study

James A. Hendrix et al.

Summary: The LIFE-DSR study aims to characterize trajectories of change in Down syndrome-associated Alzheimer's disease (DS-AD) by analyzing plasma biomarkers in adults over the age of 25. Results from the cross-sectional analysis of the first 90 subjects enrolled show strong statistical associations between biomarkers and participant age, revealing evidence of DS-AD progression beginning around the age of 40. Continued exploration of these biomarkers across the full study population will provide important insights into the onset, progression, and clinical profiles of DS-AD pathophysiology.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Computer Science, Artificial Intelligence

Verbal fl uency in normal aging and cognitive decline: Results of a longitudinal study

Claudia Frankenberg et al.

Summary: The study investigated the capability of phonemic verbal fluency as a potential predictor of cognitive decline, finding that verbal fluency deficits are present in young old age and are associated with acoustic features of spontaneous speech.

COMPUTER SPEECH AND LANGUAGE (2021)

Article Clinical Neurology

Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study

Maria Carmona-Iragui et al.

Summary: The study validated the clinical utility and prognostic value of plasma neurofilament light chain (NfL) for diagnosing symptomatic Alzheimer's disease in individuals with Down syndrome. Results showed an increasing trend in NfL concentrations over time, supporting its use as a theragnostic marker in clinical trials.

LANCET NEUROLOGY (2021)

Article Multidisciplinary Sciences

A multicentre validation study of the diagnostic value of plasma neurofilament light

Nicholas J. Ashton et al.

Nature Communications (2021)

Article Multidisciplinary Sciences

The reliability and validity of DSM 5 diagnostic criteria for neurocognitive disorder and relationship with plasma neurofilament light in a down syndrome population

Sarah E. Pape et al.

Summary: The study examined the reliability and validity of using DSM-5 criteria for neurocognitive disorder in individuals with Down syndrome, showing good inter-rater reliability and substantial concurrence with clinical judgement. The study also found that the criteria could reliably identify individuals in early stages of dementia with neurodegenerative changes.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease

Andrew J. Aschenbrenner et al.

Summary: This study identified a composite sensitive to early decline in Down syndrome (DS) without dementia, consisting of memory, language/executive functioning, selective attention, orientation, and praxis tests. This composite may have utility as an outcome measure in trials to prevent or delay symptoms of Alzheimer's disease in DS.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)

Review Education, Special

Executive function in Down syndrome: A meta-analysis

Andrew S. Tungate et al.

Summary: The meta-analysis confirmed the pronounced difficulty in executive function (EF) for individuals with Down syndrome, with specific challenges in verbal working memory/short-term memory, shifting, inhibition, and nonverbal working memory/short-term memory. The study suggests implications for interventions and future research.

RESEARCH IN DEVELOPMENTAL DISABILITIES (2021)

Article Clinical Neurology

Language skills as a predictor of cognitive decline in adults with Down syndrome

Margaret B. Pulsifer et al.

ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2020)

Article Geriatrics & Gerontology

Verbal fluency and risk of dementia

Angelina R. Sutin et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)

Article Clinical Neurology

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome

Carla M. Startin et al.

ALZHEIMERS & DEMENTIA (2019)

Article Neurosciences

Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome

Amanda Sinai et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Psychology, Clinical

Recurrent perseverations on semantic verbal fluency tasks as an early marker of cognitive impairment

Serguei V. S. Pakhomov et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2018)

Article Clinical Neurology

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome

Andre Strydom et al.

ALZHEIMERS RESEARCH & THERAPY (2018)

Article Clinical Neurology

Aging related cognitive changes associated with Alzheimer's disease in Down syndrome

Nicholas C. Firth et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)

Article Clinical Neurology

Mild Cognitive Impairments Moderate the Effect of Time on Verbal Fluency Performance

Eleni Demetriou et al.

JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2017)

Review Psychology, Clinical

The Early Presentation of Dementia in People with Down Syndrome: a Systematic Review of Longitudinal Studies

Bianca Alexandra Lautarescu et al.

NEUROPSYCHOLOGY REVIEW (2017)

Article Education, Special

A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome

M. McCarron et al.

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2017)

Review Neurosciences

A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome

Frances K. Wiseman et al.

NATURE REVIEWS NEUROSCIENCE (2015)

Article Multidisciplinary Sciences

Age-Related Changes of Adaptive and Neuropsychological Features in Persons with Down Syndrome

Alessandro Ghezzo et al.

PLOS ONE (2014)

Article Psychology, Multidisciplinary

What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults

Zeshu Shao et al.

FRONTIERS IN PSYCHOLOGY (2014)

Article Biochemistry & Molecular Biology

The population prevalence of Down's syndrome in England and Wales in 2011

Jianhua Wu et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2013)

Article Psychology, Clinical

Semantic Verbal Fluency Strategies in Amnestic Mild Cognitive Impairment

Sarah E. Price et al.

NEUROPSYCHOLOGY (2012)

Article Psychology, Clinical

Semantic verbal fluency in Alzheimer's disease: Approaches beyond the traditional scoring system

EG March et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2006)

Article Education, Special

Verbal intrusions precede memory decline in adults with Down syndrome

P Kittler et al.

JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2006)

Article Clinical Neurology

Learning and memory as a function of age in Down syndrome: A study using animal-based tasks

L Nelson et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)

Article Behavioral Sciences

Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis

JD Henry et al.

NEUROPSYCHOLOGIA (2004)